As part of move­ment to boost African pres­ence, Gri­fols to build IV bag fa­cil­i­ty in Nige­ria

In an ef­fort to curb sup­ply chain short­ages and en­able lo­cal gov­ern­ments to be more self-re­liant, Gri­fols has an­nounced its sec­ond ex­pan­sion in­to Africa in the past year.

Gri­fols will con­struct an in­tra­venous so­lu­tions plant in Nige­ria for Dozie and Dozie’s Phar­ma, a Niger­ian com­pa­ny formed to es­tab­lish spe­cial­ty med­i­cines for on­col­o­gy and im­munol­o­gy, among oth­ers.

The plant is set to be up and run­ning by 2024, and will pro­duce 5.5 mil­lion IV bags a year for the com­pa­ny.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER